Stryker's OP-I implant nears Australian approval:
This article was originally published in Clinica
Executive Summary
The Australian Drug Evaluation Committee has recommended that Stryker's OP-1 Implant be approved for the treatment of non-union long bone fractures secondary to trauma. The implant, licensed from Curis, has already received a similar recommendation in Europe, although the US FDA recently declined to grant approval. A final decision by the Australian Therapeutic Goods Agency is expected within three months.
You may also be interested in...
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.